Publicaciones en las que colabora con Domingo E. Hernández (26)

2022

  1. Treatment of early borderline lesions in low immunological risk kidney transplant patients: a Spanish multicenter, randomized, controlled parallel-group study protocol: the TRAINING study

    BMC Nephrology, Vol. 23, Núm. 1

2017

  1. Vascular Damage and Kidney Transplant Outcomes: An Unfriendly and Harmful Link

    American Journal of the Medical Sciences, Vol. 354, Núm. 1, pp. 7-16

2015

  1. Artery wall assessment helps predict kidney transplant outcome

    PLoS ONE, Vol. 10, Núm. 6

2012

  1. Type 1 diabetes increases the expression of proinflammatory cytokines and adhesion molecules in the artery wall of candidate patients for kidney transplantation

    Diabetes Care, Vol. 35, Núm. 2, pp. 427-433

2008

  1. The GLUT-1 XbaI gene polymorphism is associated with vascular calcifications in nondiabetic uremic patients

    Nephron - Clinical Practice, Vol. 108, Núm. 3

  2. The combined effect of pre-transplant triglyceride levels and the type of calcineurin inhibitor in predicting the risk of new onset diabetes after renal transplantation

    Nephrology Dialysis Transplantation, Vol. 23, Núm. 4, pp. 1436-1441

2007

  1. Carotid atheromatosis in nondiabetic renal transplant recipients: The role of prediabetic glucose homeostasis alterations

    Transplantation, Vol. 84, Núm. 7, pp. 870-875

2006

  1. ACE gene polymorphism and erythropoietin in endurance athletes at moderate altitude

    Medicine and Science in Sports and Exercise, Vol. 38, Núm. 4, pp. 688-693

  2. Impact of Metabolic Syndrome on Graft Function and Survival After Cadaveric Renal Transplantation

    American Journal of Kidney Diseases, Vol. 48, Núm. 1, pp. 134-142

  3. Presentation and role of transplantation in adult patients with type 1 primary hyperoxaluria and the I244T AGXT mutation: Single-center experience

    Kidney International, Vol. 70, Núm. 6, pp. 1115-1119

2005

  1. Eficacia de los ácidos grasos omega-3 en las enfermedades renales: ¿está justificado su empleo?

    Nefrologia, Vol. 25, Núm. 3, pp. 221-232

2004

  1. Análisis de factores de riesgo genéticos asociados a la nefropatía crónica del trasplante renal: Polimorfismos genéticos de citoquinas, moléculas de adhesión, sistema de coagulación-plaquetar y marcadores de riesgo cardiovascular

    Nefrologia, Vol. 24, Núm. SUPPL.4, pp. 49-56

  2. Role of apolipoprotein E epsilon 4 allele on chronic allograft nephropathy after renal transplantation

    Transplantation Proceedings, Vol. 36, Núm. 10, pp. 2982-2984

  3. Treatment with intermittent calcitriol and calcium reduces bone loss after renal transplantation

    Kidney International, Vol. 65, Núm. 2, pp. 705-712

2003

  1. The ACE/DD genotype is associated with the extent of exercise-induced left ventricular growth in endurance athletes

    Journal of the American College of Cardiology, Vol. 42, Núm. 3, pp. 527-532

2002

  1. Dietary fish oil does not influence acute rejection rate and graft survival after renal transplantation: A randomized placebo-controlled study

    Nephrology Dialysis Transplantation, Vol. 17, Núm. 5, pp. 897-904

2001

  1. Molecular and therapeutic progress in diabetes: future perspectives

    Nefrología : publicación oficial de la Sociedad Española Nefrologia, Vol. 21 Suppl 3, pp. 112-120

  2. Role of ACE gene polymorphism on cardiovascular complications after renal transplantation

    Transplantation Proceedings, Vol. 33, Núm. 7-8, pp. 3686-3687

2000

  1. Regression of left ventricular hypertrophy by lisinopril after renal transplantation: Role of ACE gene polymorphism

    Kidney International, Vol. 58, Núm. 2, pp. 889-897

1999

  1. The Pl(A2) polymorphism of the platelet glycoprotein IIIA gene as a risk factor for acute renal allograft rejection

    Journal of the American Society of Nephrology, Vol. 10, Núm. 12, pp. 2599-2605